Trental: Restore Healthy Blood Flow and Improve Mobility
Trental
| Product dosage: 400mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.00 (0%) | 🛒 Add to cart |
| 90 | $0.71 | $73.50 $64.00 (13%) | 🛒 Add to cart |
| 120 | $0.66 | $98.00 $79.00 (19%) | 🛒 Add to cart |
| 180 | $0.59 | $147.00 $107.00 (27%) | 🛒 Add to cart |
| 270 | $0.57 | $220.50 $153.00 (31%) | 🛒 Add to cart |
| 360 | $0.54
Best per pill | $294.00 $196.00 (33%) | 🛒 Add to cart |
Synonyms
| |||
Trental (pentoxifylline) is a prescription vasoactive and hemorheologic agent specifically formulated to improve microcirculatory blood flow. It is indicated for the symptomatic management of patients with chronic occlusive arterial disease of the limbs, a condition often associated with intermittent claudication. By enhancing the flexibility of red blood cells and reducing blood viscosity, Trental facilitates oxygen delivery to affected tissues, thereby alleviating pain and increasing pain-free walking distance. This expert guide provides a comprehensive overview of its pharmacological profile, appropriate use, and essential safety information for healthcare professionals and informed patients.
Features
- Active Ingredient: Pentoxifylline
- Pharmacologic Class: Xanthine derivative; Hemorheologic agent
- Available Formulations: 400 mg extended-release tablets
- Mechanism of Action: Improces red blood cell deformity, lowers plasma fibrinogen concentrations, and decreases platelet aggregation and hypercoagulability.
- Prescription Status: Rx-only medication
Benefits
- Increased Pain-Free Walking Distance: Clinical studies demonstrate a significant improvement in the distance patients can walk before the onset of claudication pain.
- Enhanced Tissue Oxygenation: Improves microcirculatory flow, delivering more oxygen to ischemic tissues in the extremities.
- Symptom Relief: Effectively reduces the pain, cramping, numbness, and fatigue associated with peripheral arterial disease.
- Improved Red Blood Cell Flexibility: Alters the rheological properties of blood, allowing for easier passage through constricted vessels.
- Adjunct to Lifestyle Modification: Serves as a pharmacological component of a comprehensive treatment plan that includes smoking cessation, exercise, and dietary management.
Common use
Trental is primarily used for the symptomatic treatment of intermittent claudication due to chronic occlusive arterial disease affecting the limbs. This condition is most commonly a manifestation of peripheral artery disease (PAD), where atherosclerotic plaques narrow the arteries, reducing blood flow to the muscles. Symptoms include muscle pain, cramping, or weakness that is triggered by activity and relieved by rest. It is important to note that Trental is not a cure for underlying arterial disease and does not supersede the critical importance of primary interventions like smoking cessation, a supervised exercise program, and lipid management. Its role is to provide symptomatic relief and improve functional capacity as part of a holistic management strategy.
Dosage and direction
The standard adult dosage for Trental is one 400 mg tablet taken three times daily with meals. The administration with food is recommended to minimize the potential for gastrointestinal upset. The tablets are extended-release and must be swallowed whole; they should not be crushed, chewed, or divided, as this can alter the drug’s release profile and increase the risk of side effects.
Therapeutic effects are not immediate and may take several weeks to become apparent. Patients should be advised to continue treatment as prescribed. Dosage adjustments, particularly a reduction to two tablets per day (800 mg/day), may be necessary for patients who experience significant adverse effects. Dosage must be individualized based on renal function; significant dosage reduction is required in patients with severe renal impairment (creatinine clearance below 30 mL/min). The use of Trental in children is not recommended due to a lack of safety and efficacy data.
Precautions
- Blood Pressure Monitoring: Trental can cause mild hypotension. Blood pressure should be monitored periodically, especially in patients concurrently taking antihypertensive agents.
- Bleeding Risk: Pentoxifylline inhibits platelet aggregation. Use with caution in patients with inherent or acquired bleeding risks (e.g., recent surgery, peptic ulcer disease, concomitant use of anticoagulants or other antiplatelet drugs).
- Renal Impairment: Patients with renal impairment require dosage adjustment and close monitoring due to reduced drug clearance and an increased risk of accumulation and adverse events.
- Surgery: The potential for increased bleeding risk should be considered. A discussion regarding the temporary discontinuation of Trental prior to major surgical procedures is advised.
- Pregnancy and Lactation: Trental should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution is advised when administering to nursing women.
Contraindications
Trental is contraindicated in patients with a known hypersensitivity to pentoxifylline, other xanthine derivatives (such as caffeine, theophylline, theobromine), or any component of the formulation. Its use is also contraindicated in patients with a recent history of retinal hemorrhage, cerebral hemorrhage, or significant acute bleeding.
Possible side effect
As with all medications, Trental can cause side effects, although not everybody gets them. The most common side effects are related to the gastrointestinal and central nervous systems.
- Very Common (≥1/10): Dizziness, headache, gastrointestinal discomfort, nausea, vomiting.
- Common (≥1/100 to <1/10): Flushing, feeling of warmth, bloating, dyspepsia, diarrhea, anxiety, sleep disorders, tremor, blurred vision.
- Uncommon (≥1/1,000 to <1/100): Chest pain, arrhythmia, tachycardia, hypotension, anorexia, constipation, cholecystitis, pruritus, urticaria, angioedema.
- Rare (<1/1,000): Agranulocytosis, pancytopenia, thrombocytopenia, anaphylaxis.
Drug interaction
Trental has the potential to interact with several other medications, which may alter its effects or increase the risk of serious side effects.
- Antihypertensive Drugs: May potentiate the blood pressure-lowering effects, increasing the risk of hypotension.
- Anticoagulants and Antiplatelets (e.g., Warfarin, Aspirin, Clopidogrel): Concurrent use may potentiate the antithrombotic effect and significantly increase the risk of bleeding. Close monitoring of coagulation parameters is essential.
- Theophylline: Concurrent administration may lead to increased theophylline plasma levels and an increased potential for theophylline-related toxicity. Plasma level monitoring of theophylline is recommended.
- Cimetidine: Cimetidine significantly increases the serum concentration and area-under-the-curve (AUC) of pentoxifylline and its metabolites, increasing the risk of adverse effects.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Patients should not take a double dose to make up for a forgotten one. Maintaining a regular dosing schedule is important for optimal efficacy.
Overdose
Symptoms of overdose are primarily extensions of its known adverse effects, most prominently severe hypotension, flushing, drowsiness, agitation, tremor, fever, and convulsions. Seizures have been reported. In the event of a suspected overdose, symptomatic and supportive care is paramount. Treatment may include gastric lavage or activated charcoal (if ingestion was recent), careful monitoring of vital signs and cardiac function, and management of hypotension and seizures. There is no specific antidote for pentoxifylline overdose.
Storage
Trental tablets should be stored at room temperature (15°-30°C or 59°-86°F), in a tightly closed container, and protected from light and moisture. All medications must be kept out of the reach of children and pets. Unused or expired medication should be disposed of properly via a take-back program or according to FDA guidelines, and should not be flushed down the toilet or poured into a drain.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The author and publisher are not responsible for any specific health or allergy needs that may require medical supervision and are not liable for any damages or negative consequences from any treatment, action, application, or preparation, to any person reading or following the information in this document.
Reviews
- Clinical Efficacy (4.2/5): “As a vascular surgeon, I prescribe Trental for appropriate PAD patients who have failed conservative management. The results are often modest but meaningful—a 40-50 meter increase in pain-free walking distance can significantly improve a patient’s quality of life. It’s a valuable tool in our arsenal, though it works best alongside a structured exercise program.” – Dr. A. Reynolds, MD
- Patient Experience (3.8/5): “I’ve been on Trental for six months for claudication in my calves. It took a good 8 weeks to really notice a difference, but now I can walk to the mailbox and back without stopping in pain. The first few weeks I had some nausea, but taking it with a full meal helped, and it went away.” – John D., 68
- Tolerability (3.5/5): “The benefits for my mobility are clear, but I do experience occasional dizziness and an upset stomach. My doctor reduced my dose to twice a day, which helped manage the side effects while still providing most of the benefit.” – Margaret T., 72
- Specialist Endorsement (4.0/5): “In the realm of pharmacotherapy for claudication, Trental remains a well-established option with a distinct mechanism. While newer agents exist, its long-term safety profile and rheological benefits make it a reliable choice, particularly in patients where other therapies are contraindicated.” – Clinical Pharmacologist